When Do You Really Start Losing Weight on Wegovy?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain and gut, reducing hunger and slowing digestion within 24 to 72 hours of injection. However, the timeline from first dose to visible weight loss varies significantly between individuals. Understanding what to expect helps you stay committed while your body adapts to the medication.

How Fast Does Semaglutide Cause Weight Loss?

Clinical trials show that most patients experience their first measurable weight drop between 2 to 4 weeks after starting semaglutide injections. During week one, you'll likely notice reduced appetite and less interest in foods you normally crave—this happens because semaglutide immediately signals satiety to your brain. By week three or four, this appetite suppression translates into fewer calories consumed, and the scale begins to reflect that deficit.

The weight loss accelerates as your dose increases. PlexusDx starts patients on the lowest effective dose and gradually titrates upward over 4 to 6 weeks. Each dose increase can trigger another wave of appetite reduction, which means your weekly weight loss may jump noticeably when you move to a higher injection strength. Most patients lose between 0.5 and 2 pounds per week once they reach their optimal dose.

Why Some People Lose Weight Faster Than Others

Your genetic blueprint determines how efficiently your GLP-1 receptors respond to semaglutide. Two key variants—GIPR rs1800437—influence how sensitive your cells are to the medication's appetite-suppressing signal. Someone with a favorable genetic profile at these loci may feel full after eating half the portion you do, while someone with a different genetic makeup might need a higher dose to achieve the same effect.

PlexusDx offers the Precision Peptide Genetic Test to map your individual peptide-pathway genes across 14 pathways and 49 peptides. This test reveals your genetic predisposition for GLP-1 response, allowing your provider to personalize your starting dose and titration schedule rather than relying on standard protocols. Additionally, variants in the FTO and MC4R genes affect how your body regulates hunger hormones independently of GLP-1, further customizing your weight loss trajectory.

What Happens in the First Two Weeks on Semaglutide

During days one through seven, appetite suppression is your most noticeable change. Semaglutide reaches peak concentration in your bloodstream 24 to 48 hours after injection, and most patients report that their desire to snack or overeat diminishes within this window. You might eat normally during meals but feel satisfied with smaller portions, or you might forget to eat lunch entirely because hunger signals never arrive.

Weeks two through four mark the transition from appetite changes to actual weight loss. Your body has burned through glycogen stores and begun tapping fat reserves. Most patients see their first 2 to 4 pounds disappear by day 21, though this initial loss includes water weight alongside fat loss. Nausea or mild digestive changes may appear during this phase as your gastrointestinal tract adapts to slower digestion and food moving through it more gradually.

Optimizing Your Weight Loss Timeline with Personalized Dosing

PlexusDx's compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no flat per-compound pricing increases—your dose may need to go up, but your price won't. This flat-fee model removes the financial barrier to proper titration, meaning your healthcare provider can adjust your strength based on your response and genetics rather than cost constraints. Patients who receive genetic-informed dosing often reach their effective dose faster and experience fewer side effects than those on standard schedules.

The Precision Peptide Genetic Test ($298) identifies whether you're a rapid responder, moderate responder, or slow responder to GLP-1 therapy. This insight allows your provider to anticipate whether you'll need aggressive titration or a gentler increase schedule. Combined with PlexusDx's 503A compounding pharmacy quality and availability across all 50 states with no insurance required, you gain a personalized pathway to results without the delays of traditional medical practices.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose weight in my first week on semaglutide?

You'll experience appetite suppression within 24 to 72 hours, but visible weight loss typically doesn't appear until week two or three. The first week focuses on appetite adaptation as your body responds to the medication's GLP-1 receptor activation.

How much weight can I expect to lose per week?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does compounded semaglutide work as fast as name-brand Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and achieves identical weight loss timelines as brand-name versions. PlexusDx's semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan with no insurance required, making it accessible while maintaining clinical effectiveness.

What if I'm not losing weight after four weeks?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight
• Ozempic For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.